Birdwatch Note
2024-04-30 20:21:40 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Misleading The study did not show that pseudouridine modification of mRNA vaccines stimulated cancer growth. Instead it just showed it doesn't prevent cancer growth if you’re trying to make a melanoma mRNA vaccine in mice. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614103/ US age adjusted cancer rate in 2023, record low https://x.com/Truth_in_Number/status/1785085506285387893
Written by 77F3621FF8FA173FA4ACD668DF010C276EAE695AC375074FD5F7766FA71A337C
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1785372005157466154
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1785404170574401617
- noteId - 1785404170574401617
- participantId -
- noteAuthorParticipantId - 77F3621FF8FA173FA4ACD668DF010C276EAE695AC375074FD5F7766FA71A337C Participant Details
- createdAtMillis - 1714508500129
- tweetId - 1785372005157466154
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Misleading The study did not show that pseudouridine modification of mRNA vaccines stimulated cancer growth. Instead it just showed it doesn't prevent cancer growth if you’re trying to make a melanoma mRNA vaccine in mice. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614103/ US age adjusted cancer rate in 2023, record low https://x.com/Truth_in_Number/status/1785085506285387893
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-04-30 20:21:40 UTC (1714508500129) |
2024-05-01 09:38:18 UTC (1714556298819) |
CURRENTLY_RATED_HELPFUL | 2024-05-01 12:35:12 UTC (1714566912495) |
NEEDS_MORE_RATINGS | 2024-05-01 09:38:18 UTC (1714556298819) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-04-30 18:17:57 -0500 | Rating Details | |
| 2024-04-30 17:54:41 -0500 | Rating Details | |
| 2024-04-30 17:47:00 -0500 | Rating Details | |
| 2024-04-30 17:04:32 -0500 | Rating Details | |
| 2024-04-30 16:24:04 -0500 | Rating Details | |
| 2024-04-30 16:21:19 -0500 | Rating Details | |
| 2024-04-30 16:10:56 -0500 | Rating Details | |
| 2024-04-30 15:52:24 -0500 | Rating Details | |
| 2024-04-30 15:49:30 -0500 | Rating Details | |
| 2024-04-30 15:46:30 -0500 | Rating Details | |
| 2024-04-30 15:44:08 -0500 | Rating Details | |
| 2024-04-30 15:37:58 -0500 | Rating Details | |
| 2024-04-30 15:36:01 -0500 | Rating Details | |
| 2024-04-30 15:35:30 -0500 | Rating Details | |
| 2024-04-30 15:33:41 -0500 | Rating Details | |
| 2024-04-30 15:26:06 -0500 | Rating Details | |
| 2024-04-30 15:25:47 -0500 | Rating Details | |
| 2024-05-01 06:47:35 -0500 | Rating Details | |
| 2024-05-01 04:54:19 -0500 | Rating Details | |
| 2024-05-01 02:40:20 -0500 | Rating Details | |
| 2024-05-01 02:24:51 -0500 | Rating Details | |
| 2024-05-01 01:46:02 -0500 | Rating Details | |
| 2024-05-01 01:30:46 -0500 | Rating Details | |
| 2024-05-01 01:24:27 -0500 | Rating Details | |
| 2024-05-01 01:20:57 -0500 | Rating Details | |
| 2024-05-01 01:09:22 -0500 | Rating Details | |
| 2024-05-01 01:02:43 -0500 | Rating Details | |
| 2024-04-30 23:52:29 -0500 | Rating Details | |
| 2024-04-30 23:08:56 -0500 | Rating Details | |
| 2024-04-30 22:29:15 -0500 | Rating Details | |
| 2024-04-30 21:28:11 -0500 | Rating Details | |
| 2024-04-30 20:58:37 -0500 | Rating Details | |
| 2024-04-30 19:37:55 -0500 | Rating Details | |
| 2024-05-02 09:17:43 -0500 | Rating Details | |
| 2024-05-02 02:39:35 -0500 | Rating Details | |
| 2024-05-01 14:44:13 -0500 | Rating Details | |
| 2024-05-01 06:01:16 -0500 | Rating Details | |
| 2024-05-01 02:47:10 -0500 | Rating Details | |
| 2024-05-01 02:38:52 -0500 | Rating Details | |
| 2024-05-01 02:17:31 -0500 | Rating Details | |
| 2024-05-01 01:59:56 -0500 | Rating Details | |
| 2024-05-01 01:53:26 -0500 | Rating Details | |
| 2024-05-01 01:42:24 -0500 | Rating Details | |
| 2024-05-01 00:51:45 -0500 | Rating Details | |
| 2024-04-30 22:52:26 -0500 | Rating Details | |
| 2024-04-30 20:57:27 -0500 | Rating Details | |
| 2024-04-30 19:33:18 -0500 | Rating Details | |
| 2024-04-30 19:32:57 -0500 | Rating Details | |
| 2024-04-30 18:52:11 -0500 | Rating Details | |
| 2024-04-30 18:45:25 -0500 | Rating Details | |
| 2024-04-30 17:28:13 -0500 | Rating Details | |
| 2024-04-30 17:16:30 -0500 | Rating Details | |
| 2024-04-30 17:00:33 -0500 | Rating Details | |
| 2024-04-30 16:34:49 -0500 | Rating Details | |
| 2024-04-30 16:21:26 -0500 | Rating Details | |
| 2024-04-30 16:13:38 -0500 | Rating Details | |
| 2024-05-02 18:13:51 -0500 | Rating Details | |
| 2024-05-01 04:25:04 -0500 | Rating Details | |
| 2024-05-01 02:35:12 -0500 | Rating Details | |
| 2024-05-01 02:34:43 -0500 | Rating Details | |
| 2024-05-01 00:46:29 -0500 | Rating Details | |
| 2024-05-01 00:19:32 -0500 | Rating Details | |
| 2024-04-30 21:41:54 -0500 | Rating Details | |
| 2024-04-30 19:37:07 -0500 | Rating Details | |
| 2024-04-30 18:50:52 -0500 | Rating Details | |
| 2024-04-30 18:45:43 -0500 | Rating Details | |
| 2024-04-30 18:45:05 -0500 | Rating Details | |
| 2024-04-30 16:47:09 -0500 | Rating Details | |
| 2024-04-30 15:32:56 -0500 | Rating Details | |
| 2024-04-30 15:30:40 -0500 | Rating Details | |
| 2024-05-05 15:23:39 -0500 | Rating Details | |
| 2024-05-03 19:27:05 -0500 | Rating Details | |
| 2024-05-01 13:15:05 -0500 | Rating Details | |
| 2024-05-01 10:35:32 -0500 | Rating Details | |
| 2024-05-01 08:29:09 -0500 | Rating Details | |
| 2024-05-01 06:47:16 -0500 | Rating Details | |
| 2024-05-01 02:41:01 -0500 | Rating Details | |
| 2024-05-01 01:48:28 -0500 | Rating Details | |
| 2024-05-01 01:42:58 -0500 | Rating Details | |
| 2024-05-01 01:08:14 -0500 | Rating Details | |
| 2024-05-01 00:54:06 -0500 | Rating Details | |
| 2024-05-01 00:15:07 -0500 | Rating Details | |
| 2024-04-30 20:37:43 -0500 | Rating Details | |
| 2024-04-30 18:48:20 -0500 | Rating Details | |
| 2024-04-30 18:45:14 -0500 | Rating Details | |
| 2024-04-30 18:27:04 -0500 | Rating Details | |
| 2024-04-30 17:47:51 -0500 | Rating Details | |
| 2024-04-30 17:47:23 -0500 | Rating Details | |
| 2024-04-30 17:38:19 -0500 | Rating Details | |
| 2024-04-30 16:10:09 -0500 | Rating Details | |
| 2024-04-30 15:53:21 -0500 | Rating Details | |
| 2024-04-30 15:51:23 -0500 | Rating Details | |
| 2024-04-30 15:24:22 -0500 | Rating Details | |
| 2024-05-01 05:17:37 -0500 | Rating Details | |
| 2024-04-30 20:47:50 -0500 | Rating Details | |
| 2024-04-30 15:23:02 -0500 | Rating Details | |
| 2024-05-01 08:19:32 -0500 | Rating Details | |
| 2024-05-01 02:00:40 -0500 | Rating Details | |
| 2024-04-30 20:44:20 -0500 | Rating Details | |
| 2024-04-30 15:51:06 -0500 | Rating Details |